These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29200572)

  • 21. [Carefully reviewing the history of diagnostic scales and paying more attention to the diagnostic value of Roussel - Uclaf causality assessment method scale for drug - induced liver injury].
    Chen CW
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):801-803. PubMed ID: 27978922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperacute liver injury following intravenous fluconazole: A rare case of dose-independent hepatotoxicity.
    Gayam V; Khalid M; Dahal S; Garlapati P; Gill A
    J Family Med Prim Care; 2018; 7(2):451-454. PubMed ID: 30090793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting.
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):317-22. PubMed ID: 2272712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Criteria of drug-induced liver disorders. Report of an international consensus meeting.
    Bénichou C
    J Hepatol; 1990 Sep; 11(2):272-6. PubMed ID: 2254635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced liver injury: A 2-year retrospective study of 1169 hospitalized patients in a single medical center.
    Woo HJ; Kim HY; Choi ES; Cho YH; Kim Y; Lee JH; Jang E
    Phytomedicine; 2015 Dec; 22(13):1201-5. PubMed ID: 26598920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Causality assessment methods in drug induced liver injury: strengths and weaknesses.
    García-Cortés M; Stephens C; Lucena MI; Fernández-Castañer A; Andrade RJ
    J Hepatol; 2011 Sep; 55(3):683-691. PubMed ID: 21349301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases.
    Licata A; Puccia F; Lombardo V; Serruto A; Minissale MG; Morreale I; Giannitrapani L; Soresi M; Montalto G; Almasio PL
    Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):226-232. PubMed ID: 29120909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Danger of Herbal Tea: A Case of Acute Cholestatic Hepatitis Due to
    Ruperti-Repilado FJ; Haefliger S; Rehm S; Zweier M; Rentsch KM; Blum J; Jetter A; Heim M; Leuppi-Taegtmeyer A; Terracciano L; Bernsmeier C
    Front Med (Lausanne); 2019; 6():221. PubMed ID: 31681778
    [No Abstract]   [Full Text] [Related]  

  • 29. Thioctic acid-induced acute cholestatic hepatitis.
    Ridruejo E; Castiglioni T; Silva MO
    Ann Pharmacother; 2011 Jul; 45(7-8):e43. PubMed ID: 21672886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced cytopenia.
    Int J Clin Pharmacol Ther Toxicol; 1991 Feb; 29(2):75-81. PubMed ID: 2026468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity.
    Duzenli T; Tanoglu A; Akyol T; Kara M; Yazgan Y
    Euroasian J Hepatogastroenterol; 2019; 9(1):49-51. PubMed ID: 31988867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Montelukast induced acute hepatocellular liver injury.
    Harugeri A; Parthasarathi G; Sharma J; D'Souza GA; Ramesh M
    J Postgrad Med; 2009; 55(2):141-2. PubMed ID: 19550064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced liver injury associated with Agaricus blazei Murill which is very similar to autoimmune hepatitis.
    Hisamochi A; Kage M; Arinaga T; Ide T; Miyajima I; Ogata K; Kuwahara R; Koga Y; Kumashiro R; Sata M
    Clin J Gastroenterol; 2013 Apr; 6(2):139-44. PubMed ID: 26181451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute hepatic injury associated with varenicline in a patient with underlying liver disease.
    Franck AJ; Sliter LR
    Ann Pharmacother; 2009 Sep; 43(9):1539-43. PubMed ID: 19638471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic activation and inflammation reactions involved in carbamazepine-induced liver injury.
    Higuchi S; Yano A; Takai S; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
    Toxicol Sci; 2012 Nov; 130(1):4-16. PubMed ID: 22790970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Spectrum and Outcome of Pediatric Drug Induced Liver Injury.
    Kumar A; Sood V; Khanna R; Verma SK; Mehra N; Rawat D; Alam S
    Indian J Pediatr; 2018 Aug; 85(8):676-678. PubMed ID: 29247427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of the Roussel Uclaf Causality Assessment Method (RUCAM) to analyze the hepatic findings in a clinical trial program: evaluation of the direct thrombin inhibitor ximelagatran.
    Lewis JH; Larrey D; Olsson R; Lee WM; Frison L; Keisu M
    Int J Clin Pharmacol Ther; 2008 Jul; 46(7):327-39. PubMed ID: 18793587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute severe hepatitis with alemtuzumab and rechallenge after a year.
    Beattie W; Yan B; Sood S
    J Clin Neurosci; 2019 Feb; 60():158-160. PubMed ID: 30348589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and pathological features in 138 cases of drug-induced liver injury].
    Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute hepatitis associated with the use of levofloxacin.
    Figueira-Coelho J; Pereira O; Picado B; Mendonça P; Neves-Costa J; Neta J
    Clin Ther; 2010 Sep; 32(10):1733-7. PubMed ID: 21194596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.